Roel J. Wolterink-Klein
Rotterdam, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
NKG2A genetic deletion promotes human primary NK cell anti-tumor responses better than an anti-NKG2A monoclonal antibody.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: October 06, 2023
Neuroimmune Interactions in Peripheral Organs.
Journal: Annual review of neuroscience
Published: April 01, 2022
Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy.
Journal: Journal of hematology & oncology
Published: February 10, 2021
Neuro-mesenchymal units control ILC2 and obesity via a brain-adipose circuit.
Journal: Nature
Published: November 05, 2020
Rosuvastatin Enhances VSV-G Lentiviral Transduction of NK Cells via Upregulation of the Low-Density Lipoprotein Receptor.
Journal: Molecular therapy. Methods & clinical development
Published: February 28, 2020
Influence of Vitamin C on Lymphocytes: An Overview.
Journal: Antioxidants (Basel, Switzerland)
Published: February 08, 2018
BTK Signaling in B Cell Differentiation and Autoimmunity.
Journal: Current topics in microbiology and immunology
Published: September 06, 2015
Gata3 drives development of RORγt+ group 3 innate lymphoid cells.
Journal: The Journal of experimental medicine
Published: January 15, 2014
Enforced expression of Gata3 in T cells and group 2 innate lymphoid cells increases susceptibility to allergic airway inflammation in mice.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: January 14, 2014
Essential, dose-dependent role for the transcription factor Gata3 in the development of IL-5+ and IL-13+ type 2 innate lymphoid cells.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: June 05, 2013
Last Updated: 09/26/2026